BRIEF-Moleculin Biotech Inc Announces Additional Annamycin Patent Allowances To Enhance Global Exclusivity

Reuters
06 Mar
BRIEF-Moleculin Biotech Inc Announces Additional Annamycin Patent Allowances To Enhance Global Exclusivity

March 6 (Reuters) - Moleculin Biotech Inc MBRX.O:

  • MOLECULIN BIOTECH INC: ANNOUNCES ADDITIONAL ANNAMYCIN PATENT ALLOWANCES TO ENHANCE GLOBAL EXCLUSIVITY

  • MOLECULIN BIOTECH INC: NEW PATENTS WILL EXTEND COVERAGE TO MAJOR MARKETS OUTSIDE U.S.

Source text: ID:nPn9JBSmfa

Further company coverage: MBRX.O

(Reuters.Briefs@thomsonreuters.com)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10